Description | The p53 tumor suppressor protein plays a major role in cellular response to DNA damage and other genomic aberrations. Activation of p53 can lead to either cell cycle arrest and DNA repair or apoptosis (1). p53 is phosphorylated at multiple sites in vivo and by several different protein kinases in vitro (2, 3). DNA damage induces phosphorylation of p53 at Ser15 and Ser20 and leads to a reduced interaction between p53 and its negative regulator, the oncoprotein MDM2 (4). MDM2 inhibits p53 accumulation by targeting it for ubiquitination and proteasomal degradation (5, 6). p53 can be phosphorylated by ATM, ATR, and DNA-PK at Ser15 and Ser37. Phosphorylation impairs the ability of MDM2 to bind p53, promoting both the accumulation and activation |
Product Specific References | 1. Levine, A.J. (1997) Cell 88, 323-331. 2. Meek, D.W. (1994) Semin. Cancer Biol. 5, 203-210. 3. Milczarek, G.J. et al. (1997) Life Sci. 60, 1-11. 4. Shieh, S.Y. et al. (1997) Cell 91, 325-334. 5. Chehab, N.H. et al. (1999) Proc. Natl. Acad. Sci. USA 96, 13777-13782. 6. Honda, R. et al. (1997) FEBS Lett. 420, 25-27. 7. Tibbetts, R.S. et al. (1999) Genes Dev. 13, 152-157. 8. Shieh, S.Y. et al. (1999) EMBO J. 18, 1815-1823. 9. Hirao, A. et al. (2000) Science 287, 1824-1827. 10. Hao, M. et al. (1996) J. Biol. Chem. 271, 29380-29385. 11. Lu, H. et al. (1997) Mol. Cell. Biol. 17, 5923-5934. 12. Ullrich, S.J. et al. (1993) Proc. Natl. Acad. Sci. USA 90, 5954-5958. 13. Kohn, K.W. (1999) Mol. Biol. Cell 10, 2703-2734. 14. Lohrum, M. and Scheidtmann, K.H. (1996) Oncogene 13, 2527-2539. 15. Knippschild, U. et al. (1997) Oncogene 15, 1727-1736. 16. Oda, K. et al. (2000) Cell 102, 849-862. 17. Ito, A. et al. (2001) EMBO J. 20, 1331-1340. |